ISLAMABAD/KARACHI: Pakistan’s pharmaceutical exports have posted steady growth in the first two months of the financial year 2025–26, according to new data released by the Pakistan Bureau of Statistics (PBS). The sector’s performance, coupled with international recognition for quality and compliance, is strengthening Pakistan’s position in the global healthcare market.
During July–August 2025, Pakistan exported pharmaceutical goods worth US$64.990 million, reflecting a 4.27% increase compared to US$62.329 million in the same period of 2024. In terms of quantity, exports rose by 2.16%, reaching 14,961 metric tons compared to 14,645 metric tons last year.
On a year-on-year basis, exports of pharmaceutical goods in August 2025 surged 10.56%, rising to US$31.353 million against US$28.357 million in August 2024. However, a month-on-month comparison revealed a 6.79% dip, with exports in August 2025 lower than July’s US$33.638 million.
Global recognition and quality standards
Beyond the statistical growth, Pakistan’s pharmaceutical sector has achieved global recognition through major advances in quality standards, certifications, and compliance with international benchmarks. Supported by the Special Investment Facilitation Council (SIFC), the industry is increasingly being acknowledged for producing medicines that meet international standards.
Eight leading pharmaceutical companies in Pakistan have successfully achieved certifications from global regulatory bodies, including the World Health Organization (WHO), the International Inspection Scheme, and a UK-based certification authority. These endorsements have opened access to highly regulated markets in the United States, Europe, and Gulf countries, significantly boosting Pakistan’s credibility as a reliable supplier of quality medicines.
State-of-the-art drug testing laboratories in Faisalabad, Lahore, and Gujranwala are playing a pivotal role in ensuring compliance with stringent quality benchmarks. Experts believe these developments are a crucial step toward achieving Pakistan’s ambitious $30 billion pharma export target over the next five years.
Driving sustainable growth
Industry specialists underline that the global success of Pakistan’s pharmaceutical sector will have a multiplier effect on the national economy, creating new opportunities for export-led growth and advancing healthcare innovation. With sustained government backing and adherence to international quality frameworks, Pakistan’s pharma industry is firmly on the path to becoming a key player in global healthcare supply chains.
